Amplexd Therapeutics

Amplexd Therapeutics is developing two low-cost, novel, non-invasive therapies for the treatment of cervical intraepithelial neoplasia (precancerous cervical lesions). The first is an intravaginal suppository for low-grade CIN, and the second is a photodynamic therapy (PDT) system for high-grade CIN, each designed to selectively target tumor cells. These treatments aim to modernize the paradigm for women in developed countries by reducing the need for invasive surgeries and provide potentially life-saving care for women in low- and middle-income regions.